Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001410578-25-001336

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · May 15, 2025 16.07M sh
Cash And Equivalents Q3 2025 · Mar 31, 2025 $2.54M
Cash And Equivalents Q3 2025 · Jun 30, 2024 $4.8M
Current Liabilities Q3 2025 · Mar 31, 2025 $1.2M
Current Liabilities Q3 2025 · Jun 30, 2024 $1.36M
Current Assets Q3 2025 · Mar 31, 2025 $2.73M
Current Assets Q3 2025 · Jun 30, 2024 $4.97M
Total Assets Q3 2025 · Mar 31, 2025 $10.03M
Total Assets Q3 2025 · Jun 30, 2024 $12.82M
Shares Diluted Q3 2025 · Mar 31, 2024 11.78M sh
Shares Diluted Q3 2025 · Mar 31, 2024 11.75M sh
Capex Q3 2025 · Mar 31, 2024 $58.4K
Operating Cash Flow Q3 2025 · Mar 31, 2024 −$4.83M
Stockholders Equity Q3 2025 · Mar 31, 2024 $10.65M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.45M
Stockholders Equity Q3 2025 · Sep 30, 2023 $12.97M
Stockholders Equity Q3 2025 · Jun 30, 2023 $14.87M
Eps Diluted Q3 2025 · Mar 31, 2024 −$0.16
Eps Diluted Q3 2025 · Mar 31, 2024 −$0.51
Eps Basic Q3 2025 · Mar 31, 2024 −$0.16
Eps Basic Q3 2025 · Mar 31, 2024 −$0.51
Sga Expense Q3 2025 · Mar 31, 2024 $693.74K
Sga Expense Q3 2025 · Mar 31, 2024 $1.87M
Rd Expense Q3 2025 · Mar 31, 2024 $1.21M
Rd Expense Q3 2025 · Mar 31, 2024 $4.26M
Net Income Q3 2025 · Mar 31, 2024 −$1.85M
Net Income Q3 2025 · Mar 31, 2024 −$5.94M
Net Income Q3 2025 · Dec 31, 2023 −$2.11M
Net Income Q3 2025 · Sep 30, 2023 −$1.97M
Operating Income Q3 2025 · Mar 31, 2024 −$1.91M
Operating Income Q3 2025 · Mar 31, 2024 −$6.12M